Skip to main content
Daily market wrap · Thursday, 16 July 2026
~2 min read

Nifty flat, decliners win — dip inside a weakening advance

Fast breadth slipping, A/D negative again. The structure holds — but the internals are cooling fast.
Stage2Stocks Market Desk
Nifty 50
24,073
0% on the day
Regime
Weak but recovering
32th day · neutral-to-up
Breadth
44%
above 200-DMA · narrow
Adv / Dec
931 / 1,271
decliners ahead
52w highs / lows
180 / 87
net +93
Stage-2 share
35%
cohort widening

The tape is a pullback inside an uptrend, not a top — but it is not a clean dip either. The Nifty 50 closed flat at 24,072.8, still below its 200-day average and 8.6% off its 52-week high, while decliners beat advancers 1,271 to 931 for the second session running. The slow structural breadth gauge is still intact, but the fast gauge has slipped back to where it was a week ago and the transition flow turned net negative — 51 stocks moved out of Stage 2 against 41 moving in over the last five days. This is a dip that needs to prove itself quickly, or the 'recovering' label starts to look generous.

Trajectory: structure holds, internals cooling

The slow structural breadth gauge — the share of stocks above their 200-day average — has been remarkably stable across the last six sessions, moving in a tight band between 41% and 45%, and sits at 43.8% today. That is the floor holding. The fast short-term gauge tells a different story: it spiked to 52% on 13 July, then fell sharply to 43.9% after the -0.7% session on 14 July, and has not recovered — it is back at 43.5% today. Net new highs have stalled at 93 for three straight sessions after reaching 143 mid-week, and advancers have lost to decliners in two of the last three days. The trajectory classification is correct — this is a dip, not a top — but the fast internals are not bouncing, and a further leg down in the short-term gauge would shift that read.

Leadership: Health Care and Consumer Discretionary carry the weight

On the day, Information Technology, Consumer Discretionary and Energy led with marginal gains, though IT remains a three-month laggard at -2.5% — today's nudge does not change that picture. The durable leadership sits in Health Care, which tops both the one-month and three-month tables and is where the Stage-2 cohort is expanding fastest, with Real Estate close behind on both timeframes. Consumer Discretionary and Financials are also seeing their Stage-2 cohorts widen at pace over the last 20 days. RPG Life Sciences cleared the screen on the Health Care side; within Consumer Discretionary, Tirupati Forge and Bharat Seats are the names the screen keeps surfacing with the highest setup scores — context for where the structural strength is concentrated, not a signal to act while the fast internals are still sliding.

Leading Stage-2 setups
StockSectorSetup% 1D
Tirupati Forge LtdConsumer Discretionary9.6
Muthoot Microfin LtdFinancials9.4
Bharat Seats LtdConsumer Discretionary9.4
Lokesh Machines LtdIndustrials9.4
Triveni Engineering and Industries LtdConsumer Staples9.3
Spandana Sphoorty Financial LtdFinancials9.2
RPG Life Sciences LtdHealth Care9.2
Fusion Finance LtdFinancials9.0
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Information Technology+0.5%+1.3%-2.5%3730%
Consumer Discretionary+0.3%+3.4%+5.0%6736%
Energy+0.2%-1.1%-1.6%5232%
Industrials+0.2%+1.2%+14.1%6838%
Consumer Staples+0.1%-1.1%+3.0%5328%
Materials+0.0%-0.2%+3.9%6835%
Health Care-0.0%+7.7%+18.5%7451%
Communication Services-0.1%+4.9%+12.3%6218%
Utilities-0.5%-0.3%+9.7%6123%
Financials-0.7%+1.7%-0.2%6037%
Real Estate-0.9%+8.5%+16.0%5025%
Breadth note
180 stocks are at or near new 52-week highs today — broad participation.
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing regime read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

More market wraps